SyntekaBio Inc Cash Flow Quality Index

Latest as of June 2024: -2.40x

SyntekaBio Inc cash flow quality index. SyntekaBio Inc (226330) has a Cash Flow Quality Index of -2.40x as of June 2024. Operating cash flow of ₩-1.63 Billion is below net income of ₩677.08 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial agility of SyntekaBio Inc to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-2.40x
Operating CF / Net Income

Operating Cash Flow

₩-1.63 Billion
KRW

Net Income

₩677.08 Million
KRW

Data as of

Jun 2024
Most recent filing

Cash Flow Quality Index of SyntekaBio Inc (2018–2018)

Cash flow quality index of SyntekaBio Inc from 2018 to 2018. Historical Cash Flow Quality Index for SyntekaBio Inc across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore SyntekaBio Inc (226330) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

SyntekaBio Inc Cash Flow Quality Index by Year (2018–2018)

SyntekaBio Inc cash flow quality index by year from 2018 to 2018. Year-by-year earnings quality comparison for SyntekaBio Inc. For the full cash flow conversion analysis, see 226330 operating cash flow.

Year Quality Index Operating CF (KRW) Net Income YoY Change
2018 -0.63x ₩-2.37 Billion ₩3.75 Billion —
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.